Document Detail

Combination treatment in CTCL: the current role of bexarotene.
MedLine Citation:
PMID:  23149703     Owner:  NLM     Status:  Publisher    
Primary cutaneous T-cell lymphomas are a heterogeneous group of extranodal NH lymphomas primarily presenting in the skin without extracutaneos involvement at diagnosis. Treatment choices closely depend on clinic-pathologic entity and disease stage. Among available choices, oral bexarotene has shown efficacy and safety both in monotherapy and in association with other treatments, by virtue of its versatility and high synergism with alpha-interferon, photochemotherapy (PUVA), and chemotherapy. Moreover, when associated with a wise management of its side effects, bexarotene is well tolerated if used in long-term administration, and it is therefore a good candidate to maintenance treatment after different induction therapies. Recently, the Gruppo Italiano Linfomi Cutanei (GILC) has started some pilot studies, with the aim to investigate bexarotene potential in association with PUVA and single agent chemotherapy (as pegylated liposomal doxorubicin and gemcitabine), and as consolidation/maintenance treatment. The preliminary results of GILC pilot studies confirm the good tolerability and safety of low-intermediate dose bexarotene, and its potential synergism with PUVA and chemotherapy. In addition, its use in consolidation/maintenance has proven efficacy in improving overall response rate.
C Delfino; V Grandi; A Pileri; S Rupoli; P Quaglino; R Alterini; G Goteri; L Canafoglia; N Pimpinelli
Related Documents :
10385553 - Corticosteroids in the management of bowel obstruction on a gynecological oncology unit.
24192723 - Sequential chemotherapies for advanced gastric cancer: a retrospective analysis of 111 ...
21625183 - Management of patients with brain metastases receiving trastuzumab treatment for metast...
Publication Detail:
Journal Detail:
Title:  Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia     Volume:  147     ISSN:  0392-0488     ISO Abbreviation:  G Ital Dermatol Venereol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102852     Medline TA:  G Ital Dermatol Venereol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  573-580     Citation Subset:  -    
Division of Dermatology, Department of Critical Care Medicine and Surgery -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Advanced/aggressive CTCL: improving the efficacy of treatment.
Next Document:  Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.